Bluebird Gene Therapy Given FDA Nod Despite Safety Issues
Bluebird bio has persuaded an expert committee that the benefits of its gene therapy possibility, eli-cel, exceed the risks, at least in certain patients,...
Bispecific Blood Cancer Drug By Roche Globally Approved
Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a novel bispecific lymphoma medicine...
USFDA Warns of Heart Irritation After Novavax COVID Vaccine
Even though the company's analysis found it could reduce the likelihood of mild-to-severe disease, the US Food and Drug Administration has expressed concern about...
FDA Grants Novartis Cell Therapy For Follicular Lymphoma
The US Food and Drug Administration (FDA) has granted Novartis expedited approval for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat people with relapsed...
EMA guidance supports development of new antibiotics
As part of its efforts to support a global approach to the development of new antimicrobial medicines, EMA has published the final revised guideline...
Commercial Success In New Biopharmaceutical Innovation Era
AmerisourceBergen makes strategic investments, deploys solutions to raise its end-to-end suite of commercialization services, ushering in new monetization era.
The new era in biopharmaceutical development...
Proteros and AstraZeneca Boost Collaboration Agreement
Proteros biostructures GmbH, situated in Munich, has expanded its epigenetic medicine collaboration with AstraZeneca. This multi-year extension builds on a contract signed in June...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...